Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.

Visser BJ, Wieten RW, Kroon D, Nagel IM, BĂ©lard S, van Vugt M, Grobusch MP.

Malar J. 2014 Nov 26;13:463. doi: 10.1186/1475-2875-13-463. Review.

2.

Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013.

Liu H, Yang HL, Tang LH, Li XL, Huang F, Wang JZ, Li CF, Wang HY, Nie RH, Guo XR, Lin YX, Li M, Xu JW.

Malar J. 2014 Sep 15;13:364. doi: 10.1186/1475-2875-13-364.

3.

Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, Indonesia.

Asih PB, Syafruddin D, Leake J, Sorontou Y, Sadikin M, Sauerwein RW, Vinetz J, Baird JK.

Int J Parasitol Drugs Drug Resist. 2011 Oct 5;1(1):28-32. doi: 10.1016/j.ijpddr.2011.08.001. eCollection 2011 Dec.

4.

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies.

Naing C, Racloz V, Whittaker MA, Aung K, Reid SA, Mak JW, Tanner M.

PLoS One. 2013 Dec 3;8(12):e78819. doi: 10.1371/journal.pone.0078819. eCollection 2013. Review.

5.

In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.

Hwang J, Alemayehu BH, Reithinger R, Tekleyohannes SG, Takele Teshi, Birhanu SG, Demeke L, Hoos D, Melaku Z, Kassa M, Jima D, Malone JL, Nettey H, Green M, Poe A, Akinyi S, Udhayakumar V, Kachur SP, Filler S.

PLoS One. 2013 May 22;8(5):e63433. doi: 10.1371/journal.pone.0063433. Print 2013.

6.

Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum.

Auliff AM, Balu B, Chen N, O'Neil MT, Cheng Q, Adams JH.

PLoS One. 2012;7(7):e40416. doi: 10.1371/journal.pone.0040416. Epub 2012 Jul 9.

7.

Primaquine in vivax malaria: an update and review on management issues.

Fernando D, Rodrigo C, Rajapakse S.

Malar J. 2011 Dec 12;10:351. doi: 10.1186/1475-2875-10-351. Review.

8.

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.

Phyo AP, Lwin KM, Price RN, Ashley EA, Russell B, Sriprawat K, Lindegardh N, Singhasivanon P, White NJ, Nosten F.

Clin Infect Dis. 2011 Nov;53(10):977-84. doi: 10.1093/cid/cir631.

9.

Artemisinin combination therapy for vivax malaria.

Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN.

Lancet Infect Dis. 2010 Jun;10(6):405-16. doi: 10.1016/S1473-3099(10)70079-7. Review.

10.

Resistance to therapies for infection by Plasmodium vivax.

Baird JK.

Clin Microbiol Rev. 2009 Jul;22(3):508-34. doi: 10.1128/CMR.00008-09. Review.

11.

In silico studies on DARC.

de Brevern AG, Autin L, Colin Y, Bertrand O, Etchebest C.

Infect Disord Drug Targets. 2009 Jun;9(3):289-303. Review.

12.

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.

Hasugian AR, Tjitra E, Ratcliff A, Siswantoro H, Kenangalem E, Wuwung RM, Purba HL, Piera KA, Chalfien F, Marfurt J, Penttinen PM, Russell B, Anstey NM, Price RN.

Antimicrob Agents Chemother. 2009 Mar;53(3):1094-9. doi: 10.1128/AAC.01511-08. Epub 2008 Dec 22.

13.

Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia.

Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, Muchohi S, Kokwaro G, Aseffa A, Engers H.

Malar J. 2008 Oct 29;7:220. doi: 10.1186/1475-2875-7-220.

14.

Vivax malaria: neglected and not benign.

Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM.

Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):79-87. Review.

15.

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.

Hasugian AR, Purba HL, Kenangalem E, Wuwung RM, Ebsworth EP, Maristela R, Penttinen PM, Laihad F, Anstey NM, Tjitra E, Price RN.

Clin Infect Dis. 2007 Apr 15;44(8):1067-74. Epub 2007 Mar 5.

Supplemental Content

Support Center